Since its founding in 1997, the company has focused on the gut-kidney axis, creating science-based dietary supplements such as its flagship product, Renadyl. The AANP award honors organizations that demonstrate consistent support for practitioners and innovation within the field. According to Mike Kane, COO of Kibow Biotech, the recognition underscores the company’s alignment with patient-centered care models that prioritize long-term kidney health.
In section Releases
Kibow Biotech Receives AANP Corporation of the Year Award
The American Association of Naturopathic Physicians has named Exton-based Kibow Biotech its Corporation of the Year, citing the company’s decades-long contribution to naturopathic medicine through clinical research and the development of specialized probiotic supplements for patients managing chronic kidney conditions.
.jpg){kind=logo}
Beyond product development, the firm has maintained a presence in the naturopathic community through ongoing educational initiatives and research into how the intestinal microbiome influences renal function. By targeting inflammation and reducing harmful metabolites, the company’s portfolio—including the Kibow Fortis line—aims to support patients across various stages of care. The AANP selection committee highlighted this commitment to evidence-based practice and professional collaboration as the primary drivers for this year's distinction.
Comments (0)
No comments yet. Be the first!